CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Tolterodine Tartrate Extended-Release Capsules

Read the official FDA notice

Published
9 Apr 2025
Units affected
224 cartons
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.

Brand / company
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Codes / lots
Lot# T05393, Exp. Date: 09/30/2025
Distribution
Nationwide in the USA
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 9 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.